Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1000296-70-7
2. 2-ethylbutanoyloxymethyl (5r,6s)-6-[(1r)-1-hydroxyethyl]-7-oxo-3-[(1r,3s)-1-oxothiolan-3-yl]sulfanyl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
3. Sulopenem Etzadroxil (usan)
4. Sulopenem Etzadroxil [usan]
5. Pf-03709270
6. 492m3i304t
7. Sulopenem-etzadroxil
8. Pf 03709270
9. Schembl3412832
10. Dtxsid80635293
11. 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-(((1r,3s)-tetrahydro-1-oxido-3-thienyl)thio)-, (2-ethyl-1-oxobutoxy)methyl Ester, (5r,6s)-
12. Ex-a3685
13. Pf 03709270 (ulopenem Etzadroxil)
14. Ac-33246
15. Hy-109754
16. Cs-0033925
17. D09672
18. Q27259210
19. (2-ethyl-1-oxobutoxy)methyl (5r,6s)-6-[(1r)-1-hydroxyethyl]-7-oxo-3-[[(1r,3s)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
20. (2-ethyl-1-oxobutoxy)methyl (5r,6s)-6-[(1r)-1-hydroxyethyl]-7-oxo-3-[[(1r,3s)-tetrahydro-1-oxido-3-thienyl]thio]-4thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
21. Methylene 2-ethylbutanoate (5r,6s)-6-((1r)-1-hydroxyethyl)-7-oxo-3-(((1r,3s)-1-oxotetrahydro-1h-1.lamba.(sup 4)-thiophen-3-yl)sulfanyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
| Molecular Weight | 477.6 g/mol |
|---|---|
| Molecular Formula | C19H27NO7S3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | 477.09496572 g/mol |
| Monoisotopic Mass | 477.09496572 g/mol |
| Topological Polar Surface Area | 180 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 767 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
ABOUT THIS PAGE
A Sulopenem Etzadroxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulopenem Etzadroxil, including repackagers and relabelers. The FDA regulates Sulopenem Etzadroxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulopenem Etzadroxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulopenem Etzadroxil supplier is an individual or a company that provides Sulopenem Etzadroxil active pharmaceutical ingredient (API) or Sulopenem Etzadroxil finished formulations upon request. The Sulopenem Etzadroxil suppliers may include Sulopenem Etzadroxil API manufacturers, exporters, distributors and traders.
Sulopenem Etzadroxil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulopenem Etzadroxil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulopenem Etzadroxil GMP manufacturer or Sulopenem Etzadroxil GMP API supplier for your needs.
A Sulopenem Etzadroxil CoA (Certificate of Analysis) is a formal document that attests to Sulopenem Etzadroxil's compliance with Sulopenem Etzadroxil specifications and serves as a tool for batch-level quality control.
Sulopenem Etzadroxil CoA mostly includes findings from lab analyses of a specific batch. For each Sulopenem Etzadroxil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulopenem Etzadroxil may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulopenem Etzadroxil EP), Sulopenem Etzadroxil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulopenem Etzadroxil USP).
LOOKING FOR A SUPPLIER?
